ClassID:

96898

C07K14/47 - page 7 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#1801
20190030120
2019-01-31

TIFA antagonists and their use for treating diseases

#1802
20190023774
2019-01-24

Methods and compositions for targeting polyubiquitin

#1803
20190023762
2019-01-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#1804
20190023756
2019-01-24

EPHA2 t-cell epitope agonists and uses therefore

#1805
20190023752
2019-01-24

Budding yeast with human chromatin

#1806
20190023741
2019-01-24

Peptide exhibiting hydrolytic activity and use thereof

#1807
20190022196
2019-01-24

Compositions and methods for treating or ameliorating fibrosis, systemic sclerosis and scleroderma

#1808
20190016783
2019-01-17

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

#1809
20190016780
2019-01-17

CD27L collectin fusion proteins and encoding nucleic acids

#1810
20190016766
2019-01-17

Use of improved modulators of complement function as cancer therapeutics

#1811
20190016765
2019-01-17

ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS

#1812
20190016764
2019-01-17

Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient

#1813
20190015499
2019-01-17

DNA vaccine against virus of Yellow Fever

#1814
20190015492
2019-01-17

Peptides and combination of peptides for use in immunotherapy against various cancers

#1815
20190015477
2019-01-17

MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME

#1816
20190010448
2019-01-10

Small mobile stem cells (SMS) and uses thereof

#1817
20190010231
2019-01-10

NOVEL FUSION POLYPEPTIDE SPECIFIC FOR LAG-3 AND PD-1

#1818
20190010202
2019-01-10

Apelin peptides and uses thereof

#1819
20190010196
2019-01-10

Ubiquitin variants and uses therof as 53BP1 inhibitors

#1820
20190010191
2019-01-10

Polypeptide expressed in the stratum corneum and use thereof

#1821
20190008966
2019-01-10

Interleukin-13 binding proteins

#1822
20190008886
2019-01-10

α-synuclein expression inhibitor

#1823
20190002590
2019-01-03

Circular tandem repeat proteins

#1824
20190002524
2019-01-03

Peptides and combination of peptides for use in immunotherapy against various tumors

#1825
20190002520
2019-01-03

Triple glucagon/GLP-1/GIP receptor agonist

#1826
20190002502
2019-01-03

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

#1827
20180372744
2018-12-27

Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection through the measurement of lysophosphatidic acid

#1828
20180371411
2018-12-27

KIDNEY-SPECIFIC TUMOR VACCINE DIRECTED AGAINST KIDNEY TUMOR ANTIGEN G-250

#1829
20180371071
2018-12-27

Therapeutic DLL4 Binding Proteins

#1830
20180371051
2018-12-27

NKG2D decoys

#1831
20180371038
2018-12-27

NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN

#1832
20180371037
2018-12-27

NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN

#1833
20180371035
2018-12-27

SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF

#1834
20180371034
2018-12-27

METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES

#1835
20180369328
2018-12-27

Modulators of complement function

#1836
20180369326
2018-12-27

Peptides and methods related to ICOS signaling

#1837
20180364577
2018-12-20

Methods for detecting traumatic brain injury

#1838
20180364250
2018-12-20

Sensors and assays for ubiquitin or ubiquitin-like proteins

#1839
20180362987
2018-12-20

Targeted augmentation of nuclear gene output

#1840
20180362653
2018-12-20

Single chain fusionconstructs comprising multimeric antibody fragments fused to collagen trimerization domains

#1841
20180362606
2018-12-20

Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid

#1842
20180362601
2018-12-20

Methods and compositions for genome engineering

#1843
20180362600
2018-12-20

IMMUNOMODULATORY PROTEINS

#1844
20180360995
2018-12-20

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

#1845
20180360937
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#1846
20180360936
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#1847
20180360910
2018-12-20

Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

#1848
20180360819
2018-12-20

ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT

#1849
20180355440
2018-12-13

Marker for pancreatic cancer and intraductal papillary mucinous neoplasms

#1850
20180355372
2018-12-13

IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH

#1851
20180355357
2018-12-13

Peptide, Complex of Peptide and siRNA, and Methods of Use Thereof

#1852
20180355003
2018-12-13

Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same

#1853
20180353617
2018-12-13

SynP160, a promoter for the specific expression of genes in rod photoreceptors

#1854
20180353605
2018-12-13

Ferritin nanoparticle compositions and methods to modulate cell activity

#1855
20180353586
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1856
20180353585
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1857
20180353584
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1858
20180353583
2018-12-13

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1859
20180346901
2018-12-06

MEANS AND METHODS FOR PREPARING ENGINEERED PROTEINS BY GENETIC CODE EXPANSION IN INSECT CELLS

#1860
20180346563
2018-12-06

POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER

#1861
20180346548
2018-12-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#1862
20180346532
2018-12-06

NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN

#1863
20180346529
2018-12-06

SYNP162, a promoter for the specific expression of genes in rod photoreceptors

#1864
20180344851
2018-12-06

Engineered light-activated anion channel proteins and methods of use thereof

#1865
20180344827
2018-12-06

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1866
20180344825
2018-12-06

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1867
20180340019
2018-11-29

Peptides and combination of peptides for use in immunotherapy against various tumors

#1868
20180340012
2018-11-29

METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM

#1869
20180339030
2018-11-29

Methods and compositions for treating cancer

#1870
20180339013
2018-11-29

Collagenase-derived peptides promote tissue regeneration and wound healing

#1871
20180335429
2018-11-22

Methods to spatially profile protease activity in tissue and sections

#1872
20180334689
2018-11-22

Artificial nucleases including engineered FokI cleavage half-domains

#1873
20180334687
2018-11-22

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

#1874
20180334510
2018-11-22

Compositions and methods for modulating kinase activity

#1875
20180334499
2018-11-22

Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)

#1876
20180334486
2018-11-22

Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same

#1877
20180334483
2018-11-22

Electrically conductive protein nanofibers and biofilms

#1878
20180334482
2018-11-22

In vitro assembly of bacterial microcompartments

#1879
20180332831
2018-11-22

Rodents having a humanized gene

#1880
20180328940
2018-11-15

Platelet biomarkers and diagnostic methods for vascular diseases

#1881
20180327475
2018-11-15

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1882
20180327467
2018-11-15

Peptides for the treatment of resorptive bone disease

#1883
20180327464
2018-11-15

Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient

#1884
20180327463
2018-11-15

Peptides

#1885
20180327462
2018-11-15

Targeting proteins for degradation

#1886
20180327456
2018-11-15

Selenium-based therapies

#1887
20180325999
2018-11-15

Polypeptide-polymer conjugates and methods of use thereof

#1888
20180325918
2018-11-15

Immunoregulatory agent

#1889
20180321255
2018-11-08

Soluble MANF in pancreatic beta-cell disorders

#1890
20180320130
2018-11-08

CELL CULTURE MEDIUM AND CULTURE METHOD USING THE SAME

#1891
20180319863
2018-11-08

ANTI-HLA ASSAY AND METHODS

#1892
20180318526
2018-11-08

Auto-injector with signaling cap

#1893
20180318447
2018-11-08

Compositions and methods for improving viral vector efficiency

#1894
20180318303
2018-11-08

METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS

#1895
20180312839
2018-11-01

METHODS AND COMPOSITIONS FOR INCREASING SMN EXPRESSION

#1896
20180312826
2018-11-01

Methods and compositions for gene inactivation

#1897
20180312818
2018-11-01

Biocatalysts for ezetimibe synthesis

#1898
20180311506
2018-11-01

System comprising a nucleotide sequence encoding a volvox carteri light-activated ion channel protein (VCHR1)

#1899
20180311381
2018-11-01

Modified Polynucleotides for the production of biologics and proteins associated with human disease

#1900
20180311380
2018-11-01

Prostate-targeting adeno-associated virus serotype vectors

#1901
20180311330
2018-11-01

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#1902
20180311315
2018-11-01

Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist

#1903
20180311311
2018-11-01

METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION

#1904
20180310536
2018-11-01

PRODUCTION OF FMDV-RESISTANT LIVESTOCK BY ALLELE SUBSTITUTION

#1905
20180305422
2018-10-25

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

#1906
20180305421
2018-10-25

Follistatin in treating duchenne muscular dystrophy

#1907
20180305420
2018-10-25

Modified Tamm-Horsfall protein and related compositions and methods of use

#1908
20180305419
2018-10-25

Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum

#1909
20180303902
2018-10-25

ENGINEERED INTEGRIN BINDING PEPTIDE COMPOSITIONS

#1910
20180299451
2018-10-18

TPM4-ALK fusion protein and composition for diagnosing cancer

#1911
20180298375
2018-10-18

SECRETED PROTEINS

#1912
20180298109
2018-10-18

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS

#1913
20180298071
2018-10-18

Chimeric protein in the treatment of amyloidosis

#1914
20180298069
2018-10-18

Cell lines for screening odorant and aroma receptors

#1915
20180298068
2018-10-18

Treatment of cancer using chimeric antigen receptor and protein kinase a blocker

#1916
20180296666
2018-10-18

Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate

#1917
20180296606
2018-10-18

Extracellular vesicles with enhanced potency

#1918
20180292415
2018-10-11

Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2

#1919
20180292395
2018-10-11

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

#1920
20180291462
2018-10-11

Treatment targeting oncology and neurodegeneration

#1921
20180291072
2018-10-11

Human-derived ferritin monomer fragment and fusion polypeptide using same

#1922
20180289788
2018-10-11

Regulatory T cell epitopes, compositions and uses thereof

#1923
20180289787
2018-10-11

Regulatory T cell epitopes, compositions and uses thereof

#1924
20180289786
2018-10-11

Regulatory T cell epitopes, compositions and uses thereof

#1925
20180289785
2018-10-11

Regulatory T cell epitopes, compositions and uses thereof

#1926
20180289784
2018-10-11

Regulatory T cell epitopes, compositions and uses thereof

#1927
20180289783
2018-10-11

Regulatory T cell epitopes, compositions and uses thereof

#1928
20180289782
2018-10-11

Regulatory T cell epitopes, compositions and uses thereof

#1929
20180282730
2018-10-04

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

#1930
20180282426
2018-10-04

Neutralizing antibodies and methods of use thereof

#1931
20180282391
2018-10-04

CD8a and t cell receptor variants and methods of using same in modulating immune cell responses

#1932
20180282382
2018-10-04

Compounds and methods of treating usher syndrome III

#1933
20180280486
2018-10-04

Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25

#1934
20180280441
2018-10-04

Method for mass producing proteins in mesenchymal stem cells

#1935
20180280440
2018-10-04

In vitro production of red blood cells with sortaggable proteins

#1936
20180274042
2018-09-27

RASAL1 is a major tumor suppressor gene in thyroid cancer

#1937
20180273608
2018-09-27

Multi-epitopic construct

#1938
20180273595
2018-09-27

ERG targeted therapy

#1939
20180273593
2018-09-27

Chimeric inhibitor molecules of complement activation

#1940
20180272031
2018-09-27

Bone substitute nanocomposites and methods of synthesis using multiphosphorylated peptides

#1941
20180271964
2018-09-27

Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen

#1942
20180271070
2018-09-27

Method for generating a humanized transgenic mouse comprising a human APRIL gene

#1943
20180265927
2018-09-20

MECP2E1 gene

#1944
20180265926
2018-09-20

MECP2E1 gene

#1945
20180265848
2018-09-20

RNA preparations comprising purified modified RNA for reprogramming cells

#1946
20180265577
2018-09-20

DNA molecules encoding antibodies to tau and methods of making thereof

#1947
20180264132
2018-09-20

Combined Tissue Resonance Suppression Therapy and Autologous Polyvalent Biological Vaccine

#1948
20180258484
2018-09-13

INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF

#1949
20180258462
2018-09-13

Probes and assays for measuring E3 ligase activity

#1950
20180258155
2018-09-13

RELAXIN1 derived peptides for use in immunotherapy against various tumors

#1951
20180256680
2018-09-13

H3T3A mutant protein efficiently reduces H3T3P and causes increased cell death of rapidly dividing cells

#1952
20180256550
2018-09-13

Target for treating hepatitis B virus

#1953
20180255754
2018-09-13

Non-human animal models of retinoschisis

#1954
20180251812
2018-09-06

Compositions and methods for improved neurotoxin assays

#1955
20180251556
2018-09-06

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

#1956
20180251545
2018-09-06

Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

#1957
20180251518
2018-09-06

Peptides and combination of peptides for use in immunotherapy against various tumors

#1958
20180251517
2018-09-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1959
20180251503
2018-09-06

MULTIMERIZATION TECHNOLOGIES

#1960
20180251502
2018-09-06

COLON DISEASE TARGETS AND USES THEREOF

#1961
20180250386
2018-09-06

Combination therapies for human papillomavirus-associated diseases comprising administration of therapeutic vaccine and recombinant virus vector

#1962
20180250361
2018-09-06

Methods, compounds and compositions for modulating blood brain barrier integrity and re-myelination

#1963
20180246107
2018-08-30

Monoclonal antibody for predicting tamoxifen response in breast cancer patients

#1964
20180245088
2018-08-30

Antibody to human and mouse SEMA3A and use thereof

#1965
20180245079
2018-08-30

Methods and compositions for altering function and structure of chromatin loops and/or domains

#1966
20180244761
2018-08-30

NOVEL ANTIBODY AGAINST RIBOSOMAL PROTEIN S3 AND COMPOSITION FOR DIAGNOSING BIOLOGICAL STRESS

#1967
20180244737
2018-08-30

Opsin polypeptides and methods of use thereof

#1968
20180244736
2018-08-30

Extended recombinant polypeptides and compositions comprising same

#1969
20180244735
2018-08-30

Compositions and methods of use for recombinant human secretoglobins

#1970
20180238909
2018-08-23

Multiplex biomarker for use in evaluation of state of accumulation of amyloid B in brain, and analysis method for said evaluation

#1971
20180237540
2018-08-23

Bi-specific fusion proteins

#1972
20180237494
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#1973
20180237493
2018-08-23

Peptides and combination of peptides for use in immunotherapy against various tumors

#1974
20180237485
2018-08-23

Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof

#1975
20180237483
2018-08-23

Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia

#1976
20180237482
2018-08-23

Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, DNA, and vector

#1977
20180237404
2018-08-23

Heterocyclic compound

#1978
20180236130
2018-08-23

AMELOGENIN-CHITOSAN HYDROGEL FOR DENTIN HYPERSENSITIVITY

#1979
20180236029
2018-08-23

Isoform Nell-1 peptide

#1980
20180230456
2018-08-16

SH3 domain derivatives

#1981
20180230235
2018-08-16

POLYPEPTIDES

#1982
20180230234
2018-08-16

INHIBITION OF THE COMPLEMENT SYSTEM

#1983
20180230195
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

#1984
20180230194
2018-08-16

Peptides and combination of peptides for use in immunotherapy against various tumors

#1985
20180230188
2018-08-16

Peptides, compositions, and methods for stimulating subcutaneous adipogenesis

#1986
20180224435
2018-08-09

Methods for measuring small molecule affinity to cereblon

#1987
20180222968
2018-08-09

ANTIBODY THAT BINDS MURINE WISE PROTEIN

#1988
20180215806
2018-08-02

Tumor-selective CTLA-4 antagonists

#1989
20180215800
2018-08-02

Dominant positive hnRNP-E1 polypeptide compositions and methods

#1990
20180214565
2018-08-02

PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY

#1991
20180214545
2018-08-02

Methods and reagents for diagnosing Sjögren's Syndrome

#1992
20180209996
2018-07-26

MARKER COMPOSITION COMPRISING S1P LIPID FOR PREDICTING RISK OF OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS

#1993
20180208641
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#1994
20180208640
2018-07-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#1995
20180208535
2018-07-26

Process for the coupled production of sweet whey and lactic acid from acid whey

#1996
20180201684
2018-07-19

B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE

#1997
20180201657
2018-07-19

LIGHT-ACTIVATED, CALCIUM-GATED POLYPEPTIDE AND METHODS OF USE THEREOF

#1998
20180200363
2018-07-19

Process for producing an allergen extract

#1999
20180200362
2018-07-19

Process for Producing an Allergen Extract

#2000
20180200356
2018-07-19

Immune inducer

#2001
20180200332
2018-07-19

Methods and compositions for treating trinucleotide repeat disorders

#2002
20180200302
2018-07-19

BONE MARROW STROMAL CELL DERIVED EXTRACELLULAR MATRIX PROTEIN EXTRACT AND USES THEREOF

#2003
20180195126
2018-07-12

Compositions and methods for determining genetic polymorphisms in the TMEM216 gene

#2004
20180195050
2018-07-12

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#2005
20180195040
2018-07-12

Engineered endothelial cells expressing an ETS transcription factor

#2006
20180194823
2018-07-12

Peptides and compositions for treatment of joint damage

#2007
20180194819
2018-07-12

Binding proteins based on di-ubiquitin muteins and methods for generation

#2008
20180194818
2018-07-12

Chlorotoxin variants, conjugates, and methods for their use

#2009
20180194817
2018-07-12

Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition

#2010
20180179522
2018-06-28

Tunable endogenous protein degradation

#2011
20180172707
2018-06-21

DIAGNOSTIC TARGET

#2012
20180172693
2018-06-21

BIN1 expression as a marker of cancer

#2013
20180171416
2018-06-21

DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES

#2014
20180170990
2018-06-21

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

#2015
20180170987
2018-06-21

Cryptic polypeptides and uses thereof

#2016
20180170985
2018-06-21

CRISPR-based methods and products for increasing frataxin levels and uses thereof

#2017
20180170981
2018-06-21

Recombinant polypeptide for enhancing cell transduction efficiency of a target agent

#2018
20180170970
2018-06-21

Viral chimeric particle of potato virus X and use thereof for in vitro diagnosis of Sjögren syndrome

#2019
20180170965
2018-06-21

Peptide having antimicrobial activity against pathogens and antimicrobial peptide composition comprising the same

#2020
20180169269
2018-06-21

Methods of delivery of transgenes for treating brain diseases

#2021
20180169188
2018-06-21

Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

#2022
20180169109
2018-06-21

Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses

#2023
20180164288
2018-06-14

CELLULAR EXPRESSION MODEL OF TAU AGGREGATION

#2024
20180163214
2018-06-14

Slit2D2-HSA fusion protein and use thereof against tumours

#2025
20180161410
2018-06-14

Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification

#2026
20180161390
2018-06-14

Adiponectin peptidomimetics for treating ocular disorders

#2027
20180155421
2018-06-07

CANCER TARGETS AND USES THEREOF

#2028
20180155418
2018-06-07

IL-31 ANTIBODY COMPOSITIONS

#2029
20180155408
2018-06-07

VEGF antagonist formulations suitable for intravitreal administration

#2030
20180155403
2018-06-07

HISTONE ANTI-CANCER VACCINES

#2031
20180155402
2018-06-07

Recombinant binding proteins targeting HER2 and serum albumin, and their uses

#2032
20180153962
2018-06-07

Synergistic combination of neuronal viability factors and uses thereof

#2033
20180153776
2018-06-07

Application and uses of PRG4 and therapeutic modulation thereof

#2034
20180153172
2018-06-07

Dispersion and detachment of cell aggregates

#2035
20180148718
2018-05-31

Compounds and methods for increasing antisense activity

#2036
20180148494
2018-05-31

SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS

#2037
20180148491
2018-05-31

Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases

#2038
20180148487
2018-05-31

Toll-like receptor 4 (TLR4) antagonist

#2039
20180148485
2018-05-31

Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides

#2040
20180148484
2018-05-31

Proteins specific for CD137

#2041
20180147252
2018-05-31

Inhibitors of mitochondrial fission and methods of use thereof

#2042
20180142239
2018-05-24

Methods and compositions for the treatment of cancer or other diseases

#2043
20180142006
2018-05-24

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#2044
20180142005
2018-05-24

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#2045
20180142004
2018-05-24

Antibody producing non-human animals

#2046
20180142003
2018-05-24

ANTIBODY PRODUCING NON-HUMAN ANIMALS

#2047
20180142002
2018-05-24

Antibody producing non-human animals

#2048
20180141993
2018-05-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#2049
20180141985
2018-05-24

Anti-tumor peptides and use thereof

#2050
20180140721
2018-05-24

Frataxin expression constructs

#2051
20180140688
2018-05-24

Propionyl-CoA carboxylase compositions and uses thereof

#2052
20180136222
2018-05-17

Method for detecting and measuring endogenous complexes as a new tumour marker

#2053
20180136218
2018-05-17

Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay

#2054
20180136213
2018-05-17

METHODS FOR DIAGNOSING DISEASES ASSOCIATED WITH HUMAN SIGNAL PEPTIDE-CONTAINING MOLECULES

#2055
20180135012
2018-05-17

MEMBRANE-RECEIVER COMPLEX THERAPEUTICS

#2056
20180134770
2018-05-17

Antibody producing non-human animals

#2057
20180134758
2018-05-17

Stabilized STAT3 decoy oligonucleotides and uses therefor

#2058
20180134757
2018-05-17

Porous protein particles as carriers for actives

#2059
20180133336
2018-05-17

Targeting macula densa cells as a new therapeutic approach for kidney disease

#2060
20180127473
2018-05-10

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#2061
20180125932
2018-05-10

Modified binding proteins inhibiting the VEGF-A receptor interaction

#2062
20180125931
2018-05-10

RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS

#2063
20180125923
2018-05-10

Therapeutic peptides for cerebrovascular diseases

#2064
20180119233
2018-05-03

Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof

#2065
20180119169
2018-05-03

Transgenic mouse model for dementia

#2066
20180119121
2018-05-03

Modified cascade ribonucleoproteins and uses thereof

#2067
20180118808
2018-05-03

Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer

#2068
20180118802
2018-05-03

COMPOSITIONS COMPRISING RECEPTOR-ASSOCIATED PROTEIN (RAP) VARIANTS SPECIFIC FOR CR-CONTAINING PROTEINS AND USES THEREOF

#2069
20180118797
2018-05-03

USE OF IMMUNESUPPRESSANT RECEPTOR

#2070
20180118796
2018-05-03

Method for producing protein

#2071
20180117135
2018-05-03

CDCA1 epitope peptides for Th1 cells and vaccines containing the same

#2072
20180112200
2018-04-26

COMPOSITIONS AND METHODS FOR GENERATING ANTIGENS, ANTIBODIES, AND IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS

#2073
20180111961
2018-04-26

Protein purification by anion exchange chromatography

#2074
20180110829
2018-04-26

TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN

#2075
20180105593
2018-04-19

METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR

#2076
20180105562
2018-04-19

Immune modulator for immunotherapy and vaccine formulation

#2077
20180105556
2018-04-19

Oxidative modification improves the drugability of cell penetrating peptides as drug carriers

#2078
20180100005
2018-04-12

Peptides and combination of peptides for use in immunotherapy against various tumors

#2079
20180100001
2018-04-12

BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF

#2080
20180094302
2018-04-05

De novo engineering of site-specific molecules by tethering

#2081
20180094248
2018-04-05

Necroptosis Signaling as a Therapeutic Target for Alzheimer's Disease

#2082
20180094043
2018-04-05

Peptides and combination of peptides for use in immunotherapy against various tumors

#2083
20180092989
2018-04-05

Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same

#2084
20180092988
2018-04-05

Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs

#2085
20180092972
2018-04-05

Compositions and methods for modulating an immune response

#2086
20180087081
2018-03-29

PROTEIN EXPRESSION ENHANCING POLYPEPTIDES

#2087
20180087018
2018-03-29

Materials and methods for extended continuous flow fermentation of reduced genome bacteria

#2088
20180086822
2018-03-29

METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN

#2089
20180086807
2018-03-29

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

#2090
20180086799
2018-03-29

Proteins specific for pyoverdine and pyochelin

#2091
20180086797
2018-03-29

IMMUNOMODULATORY PROTEINS

#2092
20180085436
2018-03-29

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof

#2093
20180085428
2018-03-29

Polypeptides binding to human complement C5

#2094
20180085296
2018-03-29

TRPV3 agonists for the treatment of skin conditions

#2095
20180080046
2018-03-22

Viral vectors for the treatment of retinal dystrophy

#2096
20180078633
2018-03-22

Methods and compositions employing immunogenic fusion proteins

#2097
20180078616
2018-03-22

Adiponectin peptidomimetics for treating ocular disorders

#2098
20180074072
2018-03-15

Hybrid protein for the identification of neddylated substrates

#2099
20180073039
2018-03-15

Homologous recombination factors

#2100
20180073021
2018-03-15

Recombinant protein-based method for the delivery of silencer RNA to target the brain